Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial
- Resource Type
- article
- Source
- Bone Reports, Vol 13, Iss , Pp 100326- (2020)
- Subject
Diseases of the musculoskeletal system RC925-935 - Language
- English
- ISSN
- 2352-1872